Predicting Inflammatory Skin Disease Response to IL-23 Blockade
Clinical trial NCT04541329 · COMPLETED
Trial details
- NCT number
- NCT04541329
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2023-01-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.